Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS

This trial aims to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) for moderate to severe chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). This study is a prospective, randomized, controlled trial. A total of 68 patients with CP/CPPS will be recruited. After baseline assessment, the patients will be randomized into taVNS group (n = 34) and sham-taVNS group (n = 34). The intervention of two group will last for 4 weeks with a 8-week follow-up period after the treatment. The National Institutes of Health chronic Prostatitis Symptom Score index (NIH-CPSI), International Prostate Symptom Score Scale (IPSS), European quality of Life-5 Dimensions Questionnaire (EQ-5D), self-rating anxiety Scale (SAS) and self-rating depression scale (SDS) will be assessed. The adverse events during the whole study will be recorded detailedly.

Participants needed: 68
Trial details
Age: 18-50Biological sex: MaleType: InterventionalSponsor: Jiani WuUpdated: Nov 28, 2025Locations: 1
Eligibility criteria

Consistent with the diagnostic criteria of CP/CPPS of EAU or CAU, the clinical m... [+3]

Patients with other diseases that cause urinary symptoms were excluded: Such as... [+3]

Status: Recruiting

Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease

This study evaluates the clinical effect and safety of acupuncture combined with moxibustion in improving motor symptoms of early-stage Parkinson's Disease (PD) patients, by assessing the changes in UPDRS scores. It also explores objective factors affecting the acupuncture effect and investigates the functional MRI mechanisms of acupuncture in PD treatment.

Participants needed: 60
Trial details
Age: 30-80Biological sex: AllType: InterventionalSponsor: Jiani WuUpdated: Jul 20, 2025Locations: 1
Eligibility criteria

Diagnosed with Parkinson-plus syndromes or other secondary parkinsonism. [+9]